291 related articles for article (PubMed ID: 29928883)
1. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
[TBL] [Abstract][Full Text] [Related]
2. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
Weng T; Huang J; Wagner EJ; Ko J; Wu M; Wareing NE; Xiang Y; Chen NY; Ji P; Molina JG; Volcik KA; Han L; Mayes MD; Blackburn MR; Assassi S
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757866
[TBL] [Abstract][Full Text] [Related]
4. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
Masamha CP; Xia Z; Yang J; Albrecht TR; Li M; Shyu AB; Li W; Wagner EJ
Nature; 2014 Jun; 510(7505):412-6. PubMed ID: 24814343
[TBL] [Abstract][Full Text] [Related]
5. Involved microRNAs in alternative polyadenylation intervene in breast cancer via regulation of cleavage factor "CFIm25".
Tamaddon M; Shokri G; Hosseini Rad SMA; Rad I; Emami Razavi À; Kouhkan F
Sci Rep; 2020 Jul; 10(1):11608. PubMed ID: 32665581
[TBL] [Abstract][Full Text] [Related]
6. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer.
Zhang S; Zhang X; Lei W; Liang J; Xu Y; Liu H; Ma S
J Transl Med; 2019 Aug; 17(1):257. PubMed ID: 31391087
[TBL] [Abstract][Full Text] [Related]
8. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
[TBL] [Abstract][Full Text] [Related]
9. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
[TBL] [Abstract][Full Text] [Related]
10. SRSF3 and SRSF7 modulate 3'UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels.
Schwich OD; Blümel N; Keller M; Wegener M; Setty ST; Brunstein ME; Poser I; Mozos IRL; Suess B; Münch C; McNicoll F; Zarnack K; Müller-McNicoll M
Genome Biol; 2021 Mar; 22(1):82. PubMed ID: 33706811
[TBL] [Abstract][Full Text] [Related]
11. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
Masamha CP
Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
[TBL] [Abstract][Full Text] [Related]
12. Cleavage factor Im (CFIm) as a regulator of alternative polyadenylation.
Hardy JG; Norbury CJ
Biochem Soc Trans; 2016 Aug; 44(4):1051-7. PubMed ID: 27528751
[TBL] [Abstract][Full Text] [Related]
13. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
[TBL] [Abstract][Full Text] [Related]
14. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
Kim S; Bai Y; Fan Z; Diergaarde B; Tseng GC; Park HJ
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32844230
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
Chen W; Guo W; Li M; Shi D; Tian Y; Li Z; Wang J; Fu L; Xiao X; Liu QQ; Wang S; Huang W; Deng W
PLoS One; 2013; 8(12):e82728. PubMed ID: 24358221
[TBL] [Abstract][Full Text] [Related]
16. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
17. Implications of polyadenylation in health and disease.
Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
[TBL] [Abstract][Full Text] [Related]
18. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
Weng T; Ko J; Masamha CP; Xia Z; Xiang Y; Chen NY; Molina JG; Collum S; Mertens TC; Luo F; Philip K; Davies J; Huang J; Wilson C; Thandavarayan RA; Bruckner BA; Jyothula SS; Volcik KA; Li L; Han L; Li W; Assassi S; Karmouty-Quintana H; Wagner EJ; Blackburn MR
J Clin Invest; 2019 May; 129(5):1984-1999. PubMed ID: 30830875
[TBL] [Abstract][Full Text] [Related]
19. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.
Kubo T; Wada T; Yamaguchi Y; Shimizu A; Handa H
Nucleic Acids Res; 2006; 34(21):6264-71. PubMed ID: 17098938
[TBL] [Abstract][Full Text] [Related]
20. CstF64-Induced Shortening of the
Lin A; Ji P; Niu X; Zhao X; Chen Y; Liu W; Liu Y; Fan W; Sun Y; Miao C; Zhang S; Tan W; Lin D; Wagner EJ; Wu C
Cancer Res; 2021 Nov; 81(22):5638-5651. PubMed ID: 34607841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
